Quoin Pharmaceuticals, Ltd. Share Price & Technical Analysis
QNRX · $4.77 (-1.65%)
Healthcare / Biotechnology
$4.77
-1.65%
Quoin Pharmaceuticals, Ltd., a late-stage specialty pharmaceutical company, focuses on the development and commercialization of therapeutic products for rare and orphan diseases in the United States. The company's lead product is QRX003, a topical lotion, which is in phase 2 to treat netherton syndrome (NS); phase 1 in to treat peeling skin syndrome; and in pre-clinical stage to treat SAM syndrome…
Price chart
Seasonality
May has 2 positive and 3 negative years (last 5 years shown)
-23% return in May, 9% avg return in past 3 year May month.
-81% return in 2026, -57% avg return in past 3 years.
Swipe sideways to see all months →
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Yr | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26 | -50% | 14% | -20% | -2% | -23% | – | – | – | – | – | – | – | -81% |
| 25 | -52% | 0% | -26% | -18% | 25% | 8% | -27% | 10% | -4% | 55% | 95% | -30% | 35% |
| 24 | -26% | -23% | -65% | -26% | 9% | -26% | 2% | 4% | -20% | 54% | -19% | 4% | -133% |
| 23 | 20% | -79% | -16% | -3% | -7% | 19% | 36% | -26% | -27% | -3% | 20% | -7% | -74% |
| 22 | -22% | -22% | 20% | -41% | -21% | -30% | -57% | -24% | -29% | -18% | -12% | -17% | -272% |
Monthly return % by calendar month · historical pattern, not a forecast
Bearish · Downtrend · Weak
Quoin Pharmaceuticals, Ltd., a late-stage specialty pharmaceutical company, focuses on the development and commercialization of therapeutic products for rare and orphan diseases in the United States. The company's lead product is QRX003, a topical lotion, which is in phase 2 to treat netherton syndrome (NS); phase 1 in to treat peeling skin syndrome; and in pre-clinical stage to treat SAM syndrome and ichthyosis. It also develops QRX008 for the treatment of scleroderma, which is in pre-clinical stage; and QRX009, to treat microcystic lymphatic malformations, venous malformations, angiofibroma, and other diseases. It has a research agreement with Queensland University of Technology. Quoin Pharmaceuticals, Ltd. was founded in 2018 and is based in Ashburn, Virginia. Quoin Pharmaceuticals, Ltd. is a subsidiary of Skinvisible, Inc.
Full AI Q&A, portfolio tracking, and live alerts in the app.
Key metrics
Market cap
$11.00M
P/E ratio
—
52W high
$41.80
52W low
$4.59
Volume
28,733
Related stocks in Healthcare
Merck & Co Inc Cedear (5…
₹32,900
Abbott Laboratories Cede…
₹30,500
Eli Lilly And Company Ce…
₹25,540
Unitedhealth Group Inc C…
₹17,200
₹6,600
Frequently asked questions
- What is Quoin Pharmaceuticals, Ltd. share price today?
- Quoin Pharmaceuticals, Ltd. (QNRX) last traded around $4.77 on StockPro. Prices refresh every few minutes during market hours.
- What technical signals does QNRX have?
- StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for QNRX. Download the app for real-time alerts.
- How can I analyze Quoin Pharmaceuticals, Ltd. stock?
- Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.